On Nov 8, 2021 GeneCentric Therapeutics closed a Series B round and raised $7,500,000 from Alexandria Venture Investments, Hatteras Venture Partners, IAG Capital Partners, LabCorp, […]
Series A – Beacon Biosignals
On Nov 8, 2021 Beacon Biosignals closed a Series A round and raised $27,000,000 from Andrew Beck, Casdin Capital, General Catalyst, featuring lead investors General […]
Series B – Notable
On Nov 3, 2021 Notable closed a Series B round and raised $100,000,000 from F-Prime Capital, Greylock, ICONIQ Growth, Oak HC/FT, featuring lead investors ICONIQ […]
Series B – BrainCheck
On Nov 3, 2021 BrainCheck closed a Series B round and raised $10,000,000 from Next Coast Ventures, Nueterra Capital, S3 Ventures, SelectQuote Insurance Services, Tensility […]
Venture Round – Illumigyn
On Nov 3, 2021 Illumigyn closed a Venture – Series Unknown round and raised $33,000,000 from Ubicom Holdings, Yozma Group, featuring lead investors Ubicom Holdings, […]
Series D – Cambridge Epigenetix
On Nov 2, 2021 Cambridge Epigenetix closed a Series D round and raised $88,000,000 from Ahren Innovation Capital, GV, New Science Ventures, Sequoia Capital, Temasek […]
Series A – Aktiia
On Nov 2, 2021 Aktiia closed a Series A round and raised $17,500,000 from 415 CAPITAL, Draper Esprit, Redalpine, Translink Capital, Verve Ventures, featuring lead […]
Series D – Cambridge Epigenetix
On Nov 2, 2021 Cambridge Epigenetix closed a Series D round and raised $88,000,000 from Ahren Innovation Capital, GV, New Science Ventures, Sequoia Capital, Temasek […]
Dnurse acquired by Etao International
Oct 26, 2021 Etao International has entered into an agreement to acquire Dnurse . Etao International based at New York, New York, United States. ” […]
Grant – SeLux Diagnostics
On Oct 19, 2021 SeLux Diagnostics closed a Grant round and raised $2,800,000 from National Institutes of Health, featuring lead investors National Institutes of Health. […]
